Last updated on July 2020

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure


Brief description of study

To assess whether in-hospital administration of empagliflozin results n improvements in HF related clinical events and patient-reported outcomes (death, HFE and KCCQ-CSS as a measure of health status (symptoms and physical limitations)) in patients hospitalised for acute heart failure (de novo or decompensated chronic HF) and after initial stabilisation.

Clinical Study Identifier: NCT04157751

Find a site near you

Start Over

Cardiology Associates Research Co.

Daytona Beach, FL United States
  Connect »

Frederiksberg Hospital

Frederiksberg, Denmark
  Connect »

Willis Knighton Medical Center

Bossier City, LA United States
  Connect »

TREANT Zorggroep

Emmen, Netherlands
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.